- Home
- HONE vs ESPR Comparison
HONE vs ESPR Comparison
Compare HONE & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- ESPR
- Stock Information
- Founded
- HONE 1917
- ESPR 2008
- Country
- HONE United States
- ESPR United States
- Employees
- HONE N/A
- ESPR N/A
- Industry
- HONE Major Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- ESPR Health Care
- Exchange
- HONE Nasdaq
- ESPR Nasdaq
- Market Cap
- HONE 547.7M
- ESPR 445.6M
- IPO Year
- HONE 2016
- ESPR 2013
- Fundamental
- Price
- HONE $13.18
- ESPR $2.75
- Analyst Decision
- HONE Buy
- ESPR Buy
- Analyst Count
- HONE 3
- ESPR 6
- Target Price
- HONE $14.50
- ESPR $6.50
- AVG Volume (30 Days)
- HONE 198.2K
- ESPR 6.0M
- Earning Date
- HONE 10-23-2025
- ESPR 11-06-2025
- Dividend Yield
- HONE 2.76%
- ESPR N/A
- EPS Growth
- HONE 71.76
- ESPR N/A
- EPS
- HONE 0.65
- ESPR N/A
- Revenue
- HONE $164,819,000.00
- ESPR $268,125,000.00
- Revenue This Year
- HONE N/A
- ESPR $9.87
- Revenue Next Year
- HONE $14.24
- ESPR N/A
- P/E Ratio
- HONE $20.08
- ESPR N/A
- Revenue Growth
- HONE N/A
- ESPR N/A
- 52 Week Low
- HONE $8.89
- ESPR $0.69
- 52 Week High
- HONE $13.73
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- HONE 66.28
- ESPR 70.47
- Support Level
- HONE $12.80
- ESPR $2.37
- Resistance Level
- HONE $13.18
- ESPR $2.90
- Average True Range (ATR)
- HONE 0.27
- ESPR 0.17
- MACD
- HONE 0.00
- ESPR 0.00
- Stochastic Oscillator
- HONE 74.09
- ESPR 77.78
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.